ribociclib and Coronavirus-Infections

ribociclib has been researched along with Coronavirus-Infections* in 2 studies

Other Studies

2 other study(ies) available for ribociclib and Coronavirus-Infections

Article	Year
Treatment options for patients with HR+/HER2- advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy. Breast cancer research and treatment, 2020, Volume: 182, Issue:1 Topics: Aminopyridines; Betacoronavirus; Breast Neoplasms; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Purines; SARS-CoV-2; Triage	2020
Response to the article by Dietz et al. entitled "Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium". Breast cancer research and treatment, 2020, Volume: 182, Issue:2 Topics: Aminopyridines; Betacoronavirus; Breast Neoplasms; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Purines; SARS-CoV-2; Triage	2020

Article

Year

Treatment options for patients with HR+/HER2- advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy.

Breast cancer research and treatment, 2020, Volume: 182, Issue:1

Topics: Aminopyridines; Betacoronavirus; Breast Neoplasms; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Purines; SARS-CoV-2; Triage

2020

Response to the article by Dietz et al. entitled "Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium".

Breast cancer research and treatment, 2020, Volume: 182, Issue:2

Topics: Aminopyridines; Betacoronavirus; Breast Neoplasms; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Purines; SARS-CoV-2; Triage

2020